Evidence-Based Oncology > August 2017
Evidence-Based Oncology – August 2017
August 09, 2017 – Michael A. Thompson, MD, PhD; Jennifer J. Godden, PharmD; Scott M. Weissman, MS, CGC; Deborah Wham, MS, CGC; Amanda Wilson, MD; Antony Ruggeri, MD; Michael P. Mullane, MD; and James L. Weese, MD, FACS
Precision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.
August 10, 2017 – Joy Larsen Haidle, MS, CGC; Darci L. Sternen, MS, CGC; Jane A. Dickerson, PhD; Amelia Mroch, MS, CGC; Denise F. Needham, MS, CGC; Christine M. Riordan, MS, CGC; and Michele C. Kieke, PhD, MS, CGC
Genetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.
August 09, 2017 – Bonnie J. Addario and Daryl Pritchard, PhD
The Bonnie Addario Lung Cancer Foundation has developed a registry that can serve as a repository for data on patients with lung cancer-a means to empower patients and assist care providers to deliver personalized medicine in a patient-centered manner.
August 14, 2017 – Barry Kaplan, MD, PhD
A community oncologist's perspective on the advantages and challenges with precision medicine.
August 10, 2017 – Joseph Alvarnas, MD
As we shift to the precision-medicine model of cancer care, it is essential to develop a scalable system that can deliver these care solutions in a patient-centered, economically sustainable way.
August 14, 2017 – Eleanor M. Perfetto, PhD, MS
A reaction to Institute for Clinical and Economic Review's value assessment framework by Eleanor M. Perfetto, PhD, MS, of The National Health Council.
August 11, 2017 – Surabhi Dangi-Garimella, PhD
Syapse improves patient outcomes by providing workflow solutions that enable cancer care providers to deliver precision medicine within their organization, Ken Tarkoff, the company's CEO, told Evidence-Based Oncologyâ„˘.
August 11, 2017 – Kevin Fitzpatrick
Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the quality of care for people with cancer.
August 08, 2017 – AJMC Staff
An update on the latest developments in the world of oncology care: product approvals, clinical developments, health policy changes, and more.
August 08, 2017 – Produced by Laura Joszt
AJMC®TV interviews let you catch up with experts on what’s new and important about changes in healthcare. The interviews provide insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. You can access the video clips at ajmc.com/interviews.